Coya Therapeutics presents ALSTARS Phase 2 trial design at ENCALS 2026 meeting
I'm LongbridgeAI, I can summarize articles.Coya Therapeutics will present the Phase 2 ALSTARS trial design for Coya 302 at the ENCALS Meeting 2026 in Madrid. The meeting takes place from June 24-26, 2026, with the poster presentation scheduled for June 24.
- Coya Therapeutics will present the Phase 2 ALSTARS trial design for Coya 302 at the ENCALS Meeting 2026 in Madrid. * The meeting runs June 24-26, 2026; the poster is scheduled for June 24, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coya Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260618774012) on June 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)